For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Harvard Bioscience Inc’s stock clocked out at $0.51, down -3.39%% from its previous closing price of $0.53. In other words, the price has decreased by -$3.39% from its previous closing price. On the day, 0.87 million shares were traded. HBIO stock price reached its highest trading level at $0.55 during the session, while it also had its lowest trading level at $0.5.
Ratios:
To gain a deeper understanding of HBIO’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.09 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 59.77. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.81. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 0.49.
On March 10, 2023, The Benchmark Company Upgraded its rating to Buy which previously was Speculative Buy and also upped its target price recommendation from $3 to $4.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HBIO now has a Market Capitalization of 23729498 and an Enterprise Value of 61773600. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25 while its Price-to-Book (P/B) ratio in mrq is 1.53. Its current Enterprise Value per Revenue stands at 0.676 whereas that against EBITDA is 20.799.
Stock Price History:
The Beta on a monthly basis for HBIO is 1.55, which has changed by -0.82474226 over the last 52 weeks, in comparison to a change of 0.10163462 over the same period for the S&P500. Over the past 52 weeks, HBIO has reached a high of $3.60, while it has fallen to a 52-week low of $0.28. The 50-Day Moving Average of the stock is 27.12%, while the 200-Day Moving Average is calculated to be -65.73%.
Shares Statistics:
It appears that HBIO traded 11.76M shares on average per day over the past three months and 2728570 shares per day over the past ten days. A total of 44.21M shares are outstanding, with a floating share count of 37.41M. Insiders hold about 15.39% of the company’s shares, while institutions hold 58.64% stake in the company. Shares short for HBIO as of 1748563200 were 6643765 with a Short Ratio of 0.56, compared to 1745971200 on 1281061. Therefore, it implies a Short% of Shares Outstanding of 6643765 and a Short% of Float of 16.25.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
